Advanced search
Publication Cover
Cell Cycle Volume 12, 2013 - Issue 2
Submit an article Journal homepage
1,426
Views
41
CrossRef citations to date
0
Altmetric
Perspective

Basal/HER2 breast carcinomas

Integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin)

Begoña Martin-Castillo Unit of Clinical Research; Catalan Institute of Oncology-Girona (ICO-Girona); Catalonia, Spain; Girona Biomedical Research Institute (IDIBGi); Catalonia, Spain
,
Cristina Oliveras-Ferraros Girona Biomedical Research Institute (IDIBGi); Catalonia, Spain; Metabolism & Cancer Group; Translational Research Laboratory; Catalan Institute of Oncology-Girona (ICO-Girona); Catalonia, Spain
,
Alejandro Vazquez-Martin Girona Biomedical Research Institute (IDIBGi); Catalonia, Spain; Metabolism & Cancer Group; Translational Research Laboratory; Catalan Institute of Oncology-Girona (ICO-Girona); Catalonia, Spain
,
Silvia Cufí Girona Biomedical Research Institute (IDIBGi); Catalonia, Spain; Metabolism & Cancer Group; Translational Research Laboratory; Catalan Institute of Oncology-Girona (ICO-Girona); Catalonia, Spain
,
José Manuel Moreno Regulation of Cell Growth Laboratory, Fundación INBIOMED; Gipuzkoa, Spain
,
Bruna Corominas-Faja Girona Biomedical Research Institute (IDIBGi); Catalonia, Spain; Metabolism & Cancer Group; Translational Research Laboratory; Catalan Institute of Oncology-Girona (ICO-Girona); Catalonia, Spain
,
Ander Urruticoechea Department of Medical Oncology; Breast Unit; Catalan Institute of Oncology (ICO)-Hospital Universitari de Bellvitge-Bellvitge Research Institute (IDIBELL); Catalonia, Spain
,
Ángel G. Martín Regulation of Cell Growth Laboratory, Fundación INBIOMED; Gipuzkoa, Spain
,
Eugeni López-Bonet Girona Biomedical Research Institute (IDIBGi); Catalonia, Spain; Department of Pathology; Dr. Josep Trueta Hospital of Girona; Girona, Spain
&
Javier A. Menendez Girona Biomedical Research Institute (IDIBGi); Catalonia, Spain; Metabolism & Cancer Group; Translational Research Laboratory; Catalan Institute of Oncology-Girona (ICO-Girona); Catalonia, SpainCorrespondence[email protected], [email protected]
 show all
Pages 225-245 | Published online: 15 Jan 2012

Citations (41)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Javier A. Menendez & Ruth Lupu. (2022) Fatty acid synthase: a druggable driver of breast cancer brain metastasis. Expert Opinion on Therapeutic Targets 26:5, pages 427-444.
Read now
Elisabet Cuyàs, Begoña Martin-Castillo, Bruna Corominas-Faja, Anna Massaguer, Joaquim Bosch-Barrera & Javier A Menendez. (2015) Anti-protozoal and anti-bacterial antibiotics that inhibit protein synthesis kill cancer subtypes enriched for stem cell-like properties. Cell Cycle 14:22, pages 3527-3532.
Read now

Articles from other publishers (39)

Xiaowei Qi, Qiyun Shi, Juncheng Xuhong, Yi Zhang & Jun Jiang. (2023) Pyrotinib-based therapeutic approaches for HER2-positive breast cancer: the time is now. Breast Cancer Research 25:1.
Crossref
Adam L. Maddox, Matthew S. Brehove, Kiarash R. Eliato, Andras Saftics, Eugenia Romano, Michael F. Press, Joanne Mortimer, Veronica Jones, Daniel Schmolze, Victoria L. Seewaldt & Tijana Jovanovic-Talisman. (2022) Molecular Assessment of HER2 to Identify Signatures Associated with Therapy Response in HER2-Positive Breast Cancer. Cancers 14:11, pages 2795.
Crossref
Danhui Zhao, Xin Fu, Joseph Rohr, Yingmei Wang, Mingyang Li, Xiuming Zhang, Junhui Qin, Mengwei Xu, Chao Li, Guorui Sun, Zhe Wang & Shuangping Guo. (2021) Poor histologic tumor response after adjuvant therapy in basal-like HER2-positive breast carcinoma. Pathology - Research and Practice 228, pages 153677.
Crossref
Jun Hua, Zhe Zhang, Lili Zhang, Yan Sun & Yuan Yuan. (2021) UCP-2 inhibitor enhanced the efficacy of trastuzumab against HER2 positive breast cancer cells. Cancer Chemotherapy and Pharmacology 88:4, pages 633-642.
Crossref
Xinbo Qiao, Yixiao Zhang, Lisha Sun, Qingtian Ma, Jie Yang, Liping Ai, Jinqi Xue, Guanglei Chen, Hao Zhang, Ce Ji, Xi Gu, Haixin Lei, Yongliang Yang & Caigang Liu. (2021) Association of human breast cancer CD44-/CD24- cells with delayed distant metastasis. eLife 10.
Crossref
Zhaoqing Li, Wenying Zhuo, Lini Chen, Xun Zhang, Cong Chen, Dengdi Hu, Yongxia Chen, Jingjing Yang, Yulu Zhou, Misha Mao, Ling Xu, Siwei Ju, Jun Shen, Qinchuan Wang, Minjun Dong, Shuduo Xie, Jichun Zhou & Linbo Wang. (2021) Establishment and Characterization of a HER2-Positive Cell Line Derived From the Pleural Effusion of a Drug-Resistant Breast Cancer Patient. Frontiers in Cell and Developmental Biology 9.
Crossref
Qinghui Zheng, Mengdi Zhang, Fangfang Zhou, Long Zhang & Xuli Meng. (2021) The Breast Cancer Stem Cells Traits and Drug Resistance. Frontiers in Pharmacology 11.
Crossref
Alireza Mosayebi, Barat Mojaradi, Ali Bonyadi Naeini & Seyed Hamid Khodadad Hosseini. (2020) Modeling and comparing data mining algorithms for prediction of recurrence of breast cancer. PLOS ONE 15:10, pages e0237658.
Crossref
Afshin Derakhshani, Zohreh Rezaei, Hossein Safarpour, Morteza Sabri, Atefeh Mir, Mohammad Amin Sanati, Fatemeh Vahidian, Ali Gholamiyan Moghadam, Ali Aghadoukht, Khalil Hajiasgharzadeh & Behzad Baradaran. (2019) Overcoming trastuzumab resistance in HER2‐positive breast cancer using combination therapy. Journal of Cellular Physiology 235:4, pages 3142-3156.
Crossref
Neeraj Kumar, Dan Zhao, Dulal Bhaumik, Amit Sethi & Peter H. Gann. (2019) Quantification of intrinsic subtype ambiguity in Luminal A breast cancer and its relationship to clinical outcomes. BMC Cancer 19:1.
Crossref
Tyler Risom, Xiaoyan Wang, Juan Liang, Xiaoli Zhang, Carl Pelz, Lydia G. Campbell, Jenny Eng, Koei Chin, Caroline Farrington, Goutham Narla, Ellen M. Langer, Xiao-Xin Sun, Yulong Su, Colin J. Daniel, Mu-Shui Dai, Christiane V. Löhr & Rosalie C. Sears. (2019) Deregulating MYC in a model of HER2+ breast cancer mimics human intertumoral heterogeneity. Journal of Clinical Investigation 130:1, pages 231-246.
Crossref
I. A. Voutsadakis. (2018) HER2 in stemness and epithelial–mesenchymal plasticity of breast cancer. Clinical and Translational Oncology 21:5, pages 539-555.
Crossref
Miguel Nava, Pranabananda Dutta, Robin Farias-Eisner, Jaydutt V. Vadgama & Yanyuan Wu. (2019) Utilization of NGS technologies to investigate transcriptomic and epigenomic mechanisms in trastuzumab resistance. Scientific Reports 9:1.
Crossref
Anum K. Syed, Ryan Woodall, Jennifer G. Whisenant, Thomas E. Yankeelov & Anna G. Sorace. (2019) Characterizing Trastuzumab-Induced Alterations in Intratumoral Heterogeneity with Quantitative Imaging and Immunohistochemistry in HER2+ Breast Cancer. Neoplasia 21:1, pages 17-29.
Crossref
Fei Zhou, Yanhua Zhang, Xiufang Xu, Jingfeng Luo, Fang Yang, Linbo Wang, Shuduo Xie, Jihong Sun & Xiaoming Yang. (2018) Establishment and characterization of three stable Basal/HER2-positive breast cancer cell lines derived from Chinese breast carcinoma with identical missense mutations in the DNA-binding domain of TP53. Cancer Cell International 18:1.
Crossref
Elisabet Cuyàs, Sara Verdura, Laura Llorach-Pares, Salvador Fernández-Arroyo, Fedra Luciano-Mateo, Noemí Cabré, Jan Stursa, Lukas Werner, Begoña Martin-Castillo, Benoit Viollet, Jiri Neuzil, Jorge Joven, Alfons Nonell-Canals, Melchor Sanchez-Martinez & Javier A. Menendez. (2018) Metformin directly targets the H3K27me3 demethylase KDM6A/UTX. Aging Cell 17:4, pages e12772.
Crossref
Qing-Yun Chong, Ming-Liang You, Vijay Pandey, Arindam Banerjee, Yi-Jun Chen, Han-Ming Poh, Mengyi Zhang, Lan Ma, Tao Zhu, Salundi Basappa, Liang Liu & Peter E. Lobie. (2017) Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma. Oncotarget 8:43, pages 74188-74208.
Crossref
Deli Hong, Terri L. Messier, Coralee E. Tye, Jason R. Dobson, Andrew J. Fritz, Kenneth R. Sikora, Gillian Browne, Janet L. Stein, Jane B. Lian & Gary S. Stein. (2017) Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition. Oncotarget 8:11, pages 17610-17627.
Crossref
Feng YeXiaorong ZhongYan QiuLibo YangBing WeiZhang ZhangHong Bu. (2017) CD49f Can Act as a Biomarker for Local or Distant Recurrence in Breast Cancer. Journal of Breast Cancer 20:2, pages 142.
Crossref
Yilin Wang, Xiaolong Zhang, Zou Chao, Hsiang-Fu Kung, Marie C. Lin, Andreas Dress, Fiona Wardle, Bing-Hua Jiang & Lihui Lai. (2017) MiR-34a modulates ErbB2 in breast cancer. Cell Biology International 41:1, pages 93-101.
Crossref
Elena Pera, Elke Kaemmerer, Michael J. G. Milevskiy, Kunsala T. D. S. Yapa, Jake S. O’Donnell, Melissa A. Brown, Fiona Simpson, Amelia A. Peters, Sarah J. Roberts-Thomson & Gregory R. Monteith. (2016) The voltage gated Ca2+-channel Cav3.2 and therapeutic responses in breast cancer. Cancer Cell International 16:1.
Crossref
Ruchika Verma, Neeraj Kumar, Amit Sethi & Peter H. Gann. (2016) Detecting multiple sub-types of breast cancer in a single patient. Detecting multiple sub-types of breast cancer in a single patient.
Rajneesh Pathania, Sabarish Ramachandran, Gurusamy Mariappan, Priyanka Thakur, Huidong Shi, Jeong-Hyeon Choi, Santhakumar Manicassamy, Ravindra Kolhe, Puttur D. Prasad, Suash Sharma, Bal L. Lokeshwar, Vadivel Ganapathy & Muthusamy Thangaraju. (2016) Combined Inhibition of DNMT and HDAC Blocks the Tumorigenicity of Cancer Stem-like Cells and Attenuates Mammary Tumor Growth. Cancer Research 76:11, pages 3224-3235.
Crossref
An Na Seo, Hee Jin Lee, Eun Joo Kim, Min Hye Jang, Yu Jung Kim, Jee Hyun Kim, Sung-Won Kim, Han Suk Ryu, In Ae Park, Seock-Ah Im, Gyungyub Gong, Kyung Hae Jung, Hee Jeong Kim & So Yeon Park. (2016) Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer. British Journal of Cancer 114:10, pages 1109-1116.
Crossref
Yong SunTao LiYuanpeng ZhangQiwen Zhang. (2016) Evaluation of Left Ventricular Ejection Fractions in Breast Cancer Patients Undergoing Long-Term Trastuzumab Treatment. Medical Science Monitor 22, pages 5035-5040.
Crossref
Vinay Varadan, Maria Sandoval & Lyndsay N. Harris. 2016. Novel Biomarkers in the Continuum of Breast Cancer. Novel Biomarkers in the Continuum of Breast Cancer 155 167 .
Rong Zhu, Chun-ge Zhang, Yang Liu, Zhi-qiang Yuan, Wei-liang Chen, Shu-di Yang, Ji-zhao Li, Wen-jing Zhu, Xiao-feng Zhou, Ben-gang You & Xue-nong Zhang. (2015) CD147 monoclonal antibody mediated by chitosan nanoparticles loaded with α-hederin enhances antineoplastic activity and cellular uptake in liver cancer cells. Scientific Reports 5:1.
Crossref
Begoña Martin-Castillo, Eugeni Lopez-Bonet, Elisabet Cuyàs, Gemma Viñas, Sonia Pernas, Joan Dorca & Javier A. Menendez. (2015) Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas. Oncotarget 6:32, pages 32317-32338.
Crossref
JING HUANG, HONGZHONG LI & GUOSHENG REN. (2015) Epithelial-mesenchymal transition and drug resistance in breast cancer (Review). International Journal of Oncology 47:3, pages 840-848.
Crossref
Begoña Martin-Castillo, Eugeni Lopez-Bonet, Maria Buxó, Joan Dorca, Francesc Tuca-Rodríguez, Miguel Alonso Ruano, Ramon Colomer & Javier A. Menendez. (2015) Cytokeratin 5/6 fingerprinting in HER2-positive tumors identifies a poor prognosis and trastuzumab-resistant Basal-HER2 subtype of breast cancer. Oncotarget 6:9, pages 7104-7122.
Crossref
Yan Mao, Yuzi Zhang, Qing Qu, Meizhong Zhao, Ying Lou, Junjun Liu, Ou huang, Xiaosong Chen, Jiayi Wu & Kunwei Shen. (2015) Cancer-associated fibroblasts induce trastuzumab resistance in HER2 positive breast cancer cells. Molecular BioSystems 11:4, pages 1029-1040.
Crossref
James A. McCubrey, Stephen L. Abrams, Timothy L. Fitzgerald, Lucio Cocco, Alberto M. Martelli, Giuseppe Montalto, Melchiorre Cervello, Aurora Scalisi, Saverio Candido, Massimo Libra & Linda S. Steelman. (2015) Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis. Advances in Biological Regulation 57, pages 75-101.
Crossref
James A. McCubrey, Nicole M. Davis, Stephen L. Abrams, Giuseppe Montalto, Melchiorre Cervello, Massimo Libra, Ferdinando Nicoletti, Antonino B. D'Assoro, Lucio Cocco, Alberto M. Martelli & Linda S. Steelman. (2014) Targeting breast cancer initiating cells: Advances in breast cancer research and therapy. Advances in Biological Regulation 56, pages 81-107.
Crossref
Nicole M. Davis, Melissa Sokolosky, Kristin Stadelman, Stephen L. Abrams, Massimo Libra, Saverio Candido, Ferdinando Nicoletti, Jerry Polesel, Roberta Maestro, Antonino D’Assoro, Lyudmyla Drobot, Dariusz Rakus, Agnieszka Gizak, Piotr Laidler, Joanna Dulińska-Litewka, Joerg Basecke, Sanja Mijatovic, Danijela Maksimovic-Ivanic, Giuseppe Montalto, Melchiorre Cervello, Timothy L. Fitzgerald, Zoya N. Demidenko, Alberto M. Martelli, Lucio Cocco, Linda S. Steelman & James A. McCubrey. (2014) Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention. Oncotarget 5:13, pages 4603-4650.
Crossref
Demosthenes E Ziogas. (2014) Genome-based approaches for the diagnosis of breast cancer: a review with perspective. Breast Cancer Management 3:2, pages 173-193.
Crossref
Dimitrios H. Roukos. (2013) Genome network medicine: innovation to overcome huge challenges in cancer therapy. WIREs Systems Biology and Medicine 6:2, pages 201-208.
Crossref
Ditte Brix, Knut Clemmensen & Tuula Kallunki. (2014) When Good Turns Bad: Regulation of Invasion and Metastasis by ErbB2 Receptor Tyrosine Kinase. Cells 3:1, pages 53-78.
Crossref
Dimitrios H Roukos. (2013) Cancer heterogeneity and signaling network-based drug target. Pharmacogenomics 14:11, pages 1243-1246.
Crossref
Hasan Korkaya & Max S. Wicha. (2013) HER2 and Breast Cancer Stem Cells: More than Meets the Eye. Cancer Research 73:12, pages 3489-3493.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.